| |
|
INSHU: REAL-WORLD DATA ON SAFETY AND EFFECTIVENESS OF GLECAPREVIR/PIBRENTASVIR FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION ON OPIOID SUBSTITUTION THERAPY: LATEST RESULTS FROM THE GERMAN HEPATITIS C-REGISTRY
|
| |
| |
Reported by Jules Levin
7th International Symposium on Hepatitis Care in Substance Users (INHSU) o Cascais, Portugalo
21 September 2018
Reimer J1,2, Stoehr A3, Naumann U4, Teuber G5, Zamani C6, Mauss S7, Qurishi N8, Lohmann K9, Kleine H9, Pangerl A9, Christensen S10
7th International Symposium on Hepatitis Care in Substance Users (INHSU) o Cascais, Portugalo
21 September 2018
1Gesundheit Nord - Bremen Hospital Group, Bremen, Germany; 2. Center for Interdisciplinary Addiction Researchm University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 3. ifi-institute for interdisciplinary medicine, Hamburg, Germany;4. Praxiszentrum Kaiserdamm, Berlin, Germany; 5. Practice PD Dr. med. G. Teuber, Frankfurt am Main, Germany; 6. Practice Dr. med. C. Zamani, Hannover, Germany; 7. Center for HIV and Hepatogastroenterology, Düsseldorf, Germany; 8. Gemeinschaftspraxis Gotenring, Cologne, Germany; 9. AbbVie Inc., North Chicago, Illinois, U.S.A; 10. CIM Münster, Münster, Germany
| |
| |
| |
|
|
|
